Organogenesis Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Organogenesis Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C0161
◆発行会社(調査会社):GlobalData
◆発行日:2018年7月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Organogenesis Inc (Organogenesis) is a regenerative medicine company that operates in the areas of bioactive wound healing and soft tissue regeneration. The company’s products include apligraf and dermagraft. Its dermagraft is used for the treatment of full-thickness diabetic foot ulcers. Organogenesis’s apligraf is used for the treatment of venous leg ulcers and diabetic foot ulcers. The company’s sermagraft is indicated in conjunction with standard wound care regimens in patients with adequate blood supply to the involved foot. It serves the areas of bio-active wound healing, oral regeneration and bio-surgery. The company operates through manufacturing and distribution facilities located in San Diego, California. It operates through its offices located in Switzerland. Organogenesis is headquartered in Canton, Massachusetts, the US.

Organogenesis Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Organogenesis Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Organogenesis Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Organogenesis Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Organogenesis Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Organogenesis Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Organogenesis Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Organogenesis Raises USD20 Million in Venture Financing 10
Organogenesis Raises USD30 Million in Venture Financing 11
Partnerships 12
Advanced Medical Enters into Licensing Agreement with Organogenesis 12
Acquisition 13
Organogenesis Acquires NuTech Medical 13
Organogenesis Inc – Key Competitors 14
Organogenesis Inc – Key Employees 15
Organogenesis Inc – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Corporate Communications 17
Jun 11, 2018: Organogenesis Appoints Thomas Pearl As Vice President Of Human Resources 17
Apr 05, 2018: Former Acelity, J&J Executive Joins Organogenesis as Vice President of Global Medical & Clinical Affairs 18
Sep 19, 2017: Organogenesis Names New Chief Commercial Officer and Chief Operating Officer 19
Product News 20
Apr 24, 2018: Organogenesis Showcases New Product Offerings and Research at SAWC Spring 2018 20
Oct 20, 2017: Organogenesis Highlights Latest Wound Care Research, Launches New Amniotic Wound Care Product Line and New PuraPly Antimicrobial Wound Matrix Small Size at SAWC Fall 2017 22
Other Significant Developments 24
Jun 21, 2018: Organogenesis Announces Support of American Diabetes Association 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
Organogenesis Inc, Medical Equipment, Key Facts 2
Organogenesis Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Organogenesis Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Organogenesis Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Organogenesis Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Organogenesis Inc, Deals By Market, 2012 to YTD 2018 8
Organogenesis Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Organogenesis Raises USD20 Million in Venture Financing 10
Organogenesis Raises USD30 Million in Venture Financing 11
Advanced Medical Enters into Licensing Agreement with Organogenesis 12
Organogenesis Acquires NuTech Medical 13
Organogenesis Inc, Key Competitors 14
Organogenesis Inc, Key Employees 15
Organogenesis Inc, Other Locations 16
Organogenesis Inc, Subsidiaries 16

List of Figures
Organogenesis Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Organogenesis Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Organogenesis Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Organogenesis Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Organogenesis Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Organogenesis Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Organogenesis Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Organogenesis Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Organogenesis Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Corbion NV:企業のM&A・事業提携・投資動向
    Corbion NV - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Corbion NV Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • Rengo Co Ltd:企業の戦略・SWOT・財務情報
    Rengo Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Rengo Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Oilex Ltd (OEX):企業の財務・戦略的SWOT分析
    Summary Oilex Ltd (Oilex) is an oil and gas company that acquires, explores and develops petroleum resources. The company’s projects in Australia include STP-EPA-0106, STP-EPA-0131, and STP-EPA-0107. Its STP-EPA-0106 project is located in onshore north-western Australia. Oilex’s Indian projects are …
  • International Data Group:戦略・SWOT・企業財務分析
    International Data Group - Strategy, SWOT and Corporate Finance Report Summary International Data Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Secure Trust Bank Plc:企業の戦略・SWOT・財務情報
    Secure Trust Bank Plc - Strategy, SWOT and Corporate Finance Report Summary Secure Trust Bank Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • GS Retail Co., Ltd. (007070):企業の財務・戦略的SWOT分析
    GS Retail Co., Ltd. (007070) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • N.V. Nuon Energy:企業の戦略・SWOT・財務情報
    N.V. Nuon Energy - Strategy, SWOT and Corporate Finance Report Summary N.V. Nuon Energy - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • CyrusOne Inc:企業のM&A・事業提携・投資動向
    CyrusOne Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's CyrusOne Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • STP&I Public Company Limited:企業の戦略・SWOT・財務情報
    STP&I Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary STP&I Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Tarsa Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Tarsa Therapeutics Inc (Tarsa) is a developer of therapies for the treatment and prevention of osteoporosis and other bone related diseases. The company develops calcitonin tablet TBRIA, an oral formulation of calcitonin, a peptide hormone that inhibits bone resorption, which is used for the …
  • Cutera Inc (CUTR):企業の財務・戦略的SWOT分析
    Cutera Inc (CUTR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Inception Sciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Inception Sciences Inc (Inception Sciences) is a pharmaceutical company that offers drug discovery incubators. The company develops new companies in partnership with academic researchers and biopharmaceutical companies. It develops drugs for various indications such as fibrotic diseases, onc …
  • United Bank Of India:企業の戦略・SWOT・財務分析
    United Bank Of India - Strategy, SWOT and Corporate Finance Report Summary United Bank Of India - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • High-Tech Grunderfonds Management GmbH:企業のM&A・事業提携・投資動向
    High-Tech Grunderfonds Management GmbH - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's High-Tech Grunderfonds Management GmbH Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed repo …
  • Meijer Inc:企業の戦略・SWOT・財務情報
    Meijer Inc - Strategy, SWOT and Corporate Finance Report Summary Meijer Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Beacon Biomedical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Beacon Biomedical Inc (Beacon) is a medical diagnostic device company that offers point-of-care blood test systems. The company offers its product portfolio in the therapeutic areas of breast cancer, colorectal cancer and lung cancer. It holds two patented technologies such as signaling prot …
  • Bone Therapeutics SA (BOTHE):医療機器:M&Aディール及び事業提携情報
    Summary Bone Therapeutics SA (Bone Therapeutics) is a cell therapy company that develops autologous and allogeneic cell therapy products. The company offers pipeline products such as PREOB, an autologous osteoblastic cell therapy product used for the treatment of osteonecrosis and non-union fracture …
  • Mtr Corporation Ltd:企業の戦略・SWOT・財務分析
    Mtr Corporation Ltd - Strategy, SWOT and Corporate Finance Report Summary Mtr Corporation Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Korea National Oil Corporation-石油・ガス分野:企業M&A・提携分析
    Summary Korea National Oil Corporation (KNOC) is a state-owned integrated energy company that carries out the exploration, development and production of oil and gas, and stockpiling of petroleum resources. The company purchases and sells crude oil, distribute gasoline and gasoline oil and sells refi …
  • Summit Midstream Partners LP (SMLP):石油・ガス:M&Aディール及び事業提携情報
    Summary Summit Midstream Partners LP (SMLP) is an oil and gas company that develops, owns and operates midstream energy infrastructure assets located in unconventional shale resource basins and shale formations across North America. The company operates natural gas, crude oil, and produced water gat …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆